GlassScriptPhysician profile
Misty Dehaven
NPI 1003384603
$1,051.21
in general payments reported to CMS, 2019-2025
16 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.20 · 2022: $244 · 2023: $340 · 2024: $281 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $261.03 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $109.40 | 2021-2023 | Invega Sustenna, Invega Trinza |
| Abbvie INC. | $91.93 | 2021-2023 | |
| Neurocrine Biosciences, INC. | $79.99 | 2022-2023 | Ingrezza |
| Indivior INC. | $70.87 | 2022-2023 | Perseris |
| Teva Pharmaceuticals USA, INC. | $70.30 | 2022-2023 | Austedo, Uzedy, Austedo Xr |
| Supernus Pharmaceuticals, INC. | $61.86 | 2022-2024 | Qelbree, Qelbree |
| Alkermes, INC. | $53.03 | 2022-2023 | Aristada, Lybalvi, Aristada Initio |
| Otsuka America Pharmaceutical, INC. | $51.36 | 2024 | Abilify Maintena |
| Vanda Pharmaceuticals INC. | $50.02 | 2022-2023 | Hetlioz, Fanapt |
| Exact Sciences Corporation | $34.57 | 2024-2025 | Cologuard Collection Kit |
| Lundbeck LLC | $30.98 | 2022 | |
| Sanofi Pasteur INC. | $27.33 | 2024 | |
| Corium, LLC | $22.68 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.83 | 2024 | Trintellix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.03 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misty Dehaven listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.